Alvotech to participate in the morgan stanley 22nd annual global healthcare conference

Reykjavik, iceland, aug. 26, 2024 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its participation in the morgan stanley 22nd annual global healthcare conference in new york. members of the management team will hold an in-person fireside chat on september 5, 2024, starting at 5:35 pm edt (21:35 gmt).
ALVO Ratings Summary
ALVO Quant Ranking